“roche” Archives

in
Entry Author Date Location
Roche Gets FDA OK for Injectable Version of Breast Cancer Drug 06/29/20 San Diego
Eye Inflammation Dooms AbbVie Wet AMD Drug to an FDA Rejection 06/26/20 National
AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis 06/24/20 National
AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal 06/10/20 National
Merck’s Keytruda Fails Pivotal Bladder Cancer Study, Sinks First-Line Hopes 06/10/20 New York
Sarepta Eyes Key Test for Gene Therapy in Rare Muscular Dystrophy 06/08/20 Boston
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Vividion Gets $135M in Collaboration With Roche on Protein Degradation 05/20/20 San Diego
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Erasca Lands $200M Mega-Round to Move Cancer Programs to the Clinic 04/27/20 San Diego
ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans 04/27/20 New York
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics 04/08/20 Boston
Pandion Pulls In $80M as Ulcerative Colitis Drug Advances in Clinic 04/01/20 Boston
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy 03/31/20 Raleigh Durham
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Forge Inks Roche Deal For Antibiotic Aimed at Drug-Resistant Infections 03/26/20 San Diego
Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects 03/05/20 San Diego
Amunix Raises $73M to Bring Safer T Cell Engagers to Solid Tumors 03/04/20 San Francisco
ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers 03/02/20 San Francisco
Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact 02/25/20 Boston
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer 02/12/20 San Francisco
Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential 02/12/20 San Diego
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 02/12/20 National
Page 1 of 26 next page »